RETROSPECTIVE COMPARISON OF RADICAL RETROPUBIC PROSTATECTOMY AND ¹²⁵ IODINE BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER

Abstract

Radical prostatectomy yielded a proportionately but not statistically significant higher 7-year probability of nonprogression than 125I brachytherapy in patients with favorable clinicopathological characteristics. Comparisons are confounded by residual differences in clinicopathological features of tumors between groups and different treatment end points to determine outcomes. Further prospective, randomized clinical trials are required for valid comparisons.